Clinical Trial

Breast and Gynecological Cancer Treatments

Study Description

The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

This is a pilot study to test whether PYC can improve climacteric symptoms for women who have experienced either surgically or medically induced menopause as part of their treatment for breast or gynecologic cancers.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Dietary Supplement - 50 mg PYC and then placebo

4 weeks on PYC, then 4 weeks on placebo

Dietary Supplement - 100 mg PYC and then placebo

4 weeks on PYC, then 4 weeks on placebo

Dietary Supplement - Placebo and then 50 mg PYC

4 weeks on placebo, then 4 weeks on PYC

Dietary Supplement - Placebo and then 100 mg PYC

4 weeks on placebo, then 4 weeks of PYC

Additional Information

Official Study Title

The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments

Clinical Trial ID

NCT03704454

ParticipAid ID

dL9Jwe